With many years of consulting experience across global pharma, biotech, and MedTech markets, Minaz brings deep domain expertise, strategic clarity, and analytical rigor to every engagement. She has led 130+ consulting assignments spanning market entry, competitive landscaping, and portfolio prioritization, helping clients navigate complex, high-stakes decisions with confidence. Known for her ability to synthesize primary and secondary research into executive-ready recommendations, Minaz has built forecasting models and market sizing frameworks that have informed multi-million dollar investment decisions in oncology, diagnostics, and peptide therapeutics. Beyond her analytical strength, Minaz is a trusted client partner, translating complex datasets into clear, actionable insights for senior stakeholders. She currently leads a team of research analysts, driving business expansion, and shaping client engagement strategy.
